Galec­to lays off 70% of staff, con­sid­ers strate­gic al­ter­na­tives af­ter IPF tri­al fail

Boston-based Galec­to is lay­ing off 70% of its em­ploy­ees and ex­plor­ing a range of strate­gic al­ter­na­tives a lit­tle over a month af­ter it had to axe its lead can­di­date in lung dis­ease fol­low­ing a failed tri­al.

Galec­to hint­ed at the po­ten­tial for changes in mid-Au­gust when it an­nounced the mid-stage flop, adding that it was  “eval­u­at­ing re­source al­lo­ca­tion” to ex­tend its cash run­way in 2025. Galec­to said Tues­day that it will lay off around 29 peo­ple and will seek a merg­er, ac­qui­si­tion or di­vesti­ture.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER